Listen as we reveal exciting new results from our pivotal CLiMB trial, which compares the sensitivity and specificity of the HelioLiver multi-analyte blood test to ultrasound for detection of hepatocellular carcinoma (HCC) within a population at high risk of HCC due to liver cirrhosis.
Watch on YouTube
Results are presented by Mindie H. Nguyen, MD, MAS (Stanford University Medical Center), Lead Principal Investigator for the CLiMB trial, followed by a Q&A from the audience to Helio’s KOLs and management team.
Watch the full presentation on YouTube, or download the Helio Genomics NASDAQ investor day presentation (PDF).